Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001165527-12-000146
Filing Date
2012-02-21
Accepted
2012-02-21 08:20:48
Documents
10
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 g5765.txt 10-Q 61775
2 ex31-1.txt EX-31.1 3809
3 ex31-2.txt EX-31.2 3789
4 ex32-1.txt EX-32.1 1432
  Complete submission text file 0001165527-12-000146.txt   1105273

Data Files

Seq Description Document Type Size
5 vnth-20111231.xml EX-101.INS 116488
6 vnth-20111231.xsd EX-101.SCH 16558
7 vnth-20111231_cal.xml EX-101.CAL 6452
8 vnth-20111231_def.xml EX-101.DEF 60490
9 vnth-20111231_lab.xml EX-101.LAB 109142
10 vnth-20111231_pre.xml EX-101.PRE 73537
Mailing Address 11400 OLYMPIC BLVD., SUITE 640 LOS ANGELES CA 90064
Business Address 11400 OLYMPIC BLVD., SUITE 640 LOS ANGELES CA 90064 310-477-5811
Vantage Health (Filer) CIK: 0001497130 (see all company filings)

EIN.: 980659770 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 333-168930 | Film No.: 12624987
SIC: 2834 Pharmaceutical Preparations